Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment

    Investment - Page 2

    Elbrit Life Sciences to expand production capacity with over Rs 13 crore investment

    Elbrit Life Sciences to expand production capacity with over Rs 13 crore investment

    Medical Dialogues Bureau5 July 2019 9:45 AM IST
    Elbrit Life Sciences currently owns a manufacturing facility in Pondicherry with a capacity to manufacture 2 million units of solid dosage...
    Akshay Kumar joins fitness tech startup GOQii as investor, strategic advisor

    Akshay Kumar joins fitness tech startup GOQii as investor, strategic advisor

    Farhat Nasim1 July 2019 3:43 PM IST
    NEW DELHI: The 'Khiladi' of Bollywood Akshay Kumar has recently invested an undisclosed amount in GOQii, a fitness technology venture that offers a...
    Indian Immunologicals invests Rs 75 crore to set up new Sterile Filling Facility in Telangana

    Indian Immunologicals invests Rs 75 crore to set up new Sterile Filling Facility in Telangana

    Farhat Nasim25 Jun 2019 11:36 AM IST
    With this investment of Rs 75 crores in the upcoming filling facility, Indian Immunologicals Limited expects to increase its capacity to supply...
    Caplin Points sterile injectable site in Chennai gets two USFDA observations

    Caplin Point's sterile injectable site in Chennai gets two USFDA observations

    Medical Dialogues Bureau20 Jun 2019 1:34 PM IST
    New Delhi: Caplin Point Laboratories Monday said the US health regulator has made two observations after completion of inspection at its subsidiary's...
    China province eyeing investment opportunities in Indian medical sector

    China province eyeing investment opportunities in Indian medical sector

    Medical Dialogues Bureau16 Jun 2019 9:15 AM IST
    "There is a great opportunity to work in industries such as medical and IT between India and Yunnan. There are many business councils and associations...
    Japanese regulator PMDA completes inspection of Lupin Mandideep facility unit, no major observations

    Japanese regulator PMDA completes inspection of Lupin Mandideep facility unit, no major observations

    Medical Dialogues Bureau6 Jun 2019 2:05 PM IST
    New Delhi: Drug firm Lupin Tuesday said Japanese regulatory agency, PMDA, has concluded the inspection of Unit 2 at Mandideep facility in Madhya...
    AstraZeneca opens new development operations centre in Bengaluru

    AstraZeneca opens new development operations centre in Bengaluru

    Medical Dialogues Bureau1 Jun 2019 3:05 PM IST
    Bengaluru: Drug firm AstraZeneca Thursday said it has opened a new development operations centre in Bengaluru to support the expansion of its clinical...
    Amgen to buy Nuevolution for $167 million

    Amgen to buy Nuevolution for $167 million

    Garima26 May 2019 9:10 AM IST
    Amgen, which is grappling with competition to its new migraine treatment Aimovig and cholesterol fighter Repatha, said it had collaborated with...
    Lupin launches generic version of Pulmicort Respules Inhalation Suspension

    Lupin launches generic version of Pulmicort Respules Inhalation Suspension

    Farhat Nasim23 May 2019 9:30 AM IST
    Lupin's product is a generic version of AstraZeneca Pharmaceuticals LP's Pulmicort Respules Inhalation Suspension, 0.5 mg/2 mL.New Delhi: Drug maker...
    Varian to acquire Cancer Treatment Services International for Rs 1980 crore

    Varian to acquire Cancer Treatment Services International for Rs 1980 crore

    Garima22 May 2019 9:30 AM IST
    These fast-growing offerings will allow Varian to expand its solutions while helping to support the continued growth trajectory of the company’s...
    Alphabets GV leads $58.5 million investment to launch Verve Therapeutics

    Alphabet's GV leads $58.5 million investment to launch Verve Therapeutics

    Garima9 May 2019 9:15 AM IST
    Verve Therapeutics plans to target adults at risk of coronary artery disease, the leading cause of death worldwide, by editing their genes to mirror...
    Everstone acquires stake in Chennai based CPC Diagnostics

    Everstone acquires stake in Chennai based CPC Diagnostics

    Garima14 March 2019 4:59 PM IST
    The strategic partnership with Everstone Group will help CPC Diagnostics take its product portfolio to new customers and markets, the Chennai-based...
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    Coronavirus Impact: Indian Pharma Exports to miss 22 Billion target, says Pharmexcil

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok